Transforming growth factor β signal transduction: A potential target for maintenance/restoration of transparency of the Cornea

Eye and Contact Lens

Volumn 36, Issue 5, 2010, Pages 286-289

  Saika, Shizuya ^a   Yamanaka, Osamu ^a   Sumioka, Takayoshi ^a   Okada, Yuka ^a   Miyamoto, Takeshi ^a   Shirai, Kumi ^a   Kitano, Ai ^a   Tanaka, Sai Ichi ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cornea; Endothelium; Epithelial mesenchymal transition; Gene transfer; Keratocyte; Myofibroblast; Signal transduction; Smad; Transforming growth factor

Indexed keywords

CYTOKINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOGENIC PROTEIN 1; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD7 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; TUMOR NECROSIS FACTOR ALPHA;

CAUSTIC BURN; CELL DIFFERENTIATION; CELL TRANSDIFFERENTIATION; CORNEA CELL; CORNEA ENDOTHELIUM; CORNEA OPACITY; CORNEA SCAR; CORNEA STROMA; DESCEMET MEMBRANE; FIBROGENESIS; GENE TRANSFER; HUMAN; INFLAMMATORY CELL; KERATITIS; MACROPHAGE; MOUSE; MYOFIBROBLAST; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OCULAR FIBROSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; SCAR; SCAR FORMATION; SIGNAL TRANSDUCTION; TISSUE REPAIR;

CELL TRANSDIFFERENTIATION; CORNEA; CORNEAL DISEASES; ENDOTHELIUM, CORNEAL; FIBROSIS; GENE TRANSFER TECHNIQUES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; MYOFIBROBLASTS; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 77957567725     PISSN: 15422321     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICL.0b013e3181eef01c     Document Type: Review

References (34)

1. Imanishi J, Kamiyama K, Iguchi I., et al. Growth factors: Importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res 2000; 19: 113-129.
2. Suzuki K, Saito J, Yanai R., et al. Cell-matrix and cell-cell interactions during corneal epithelial wound healing. Prog Retin Eye Res 2003; 22: 113-133.
3. Fini ME. Keratocyte and fibroblast phenotypes in the repairing cornea. Prog Retin Eye Res 1999; 18: 529-551.
4. Saika S, Yamanaka O, Sumioka T., et al. Fibrotic disorders in the eye: Targets of gene therapy. Prog Retin Eye Res 2008; 27: 177-196.
5. Nishida K, Yamato M, Hayashida Y., et al. Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium. N Engl J Med 2004; 351: 1187-1196.
6. Tomasek JJ, Gabbiani G, Hinz B., et al. Myofibroblasts and mechanoregulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002; 3: 349-363.
7. Wynn TA. Fibrotic diseases. Review series. J Clin Invest 2007; 117: 524-586.
8. Roberts AB, Tian F, Byfield S.D., et al. Smad3 is key to TGF-b-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis. Cytokine Growth Factor Rev 2006; 17: 19-27.
9. Ten Dijke P., Goumans MJ, Itoh F, et al. Regulation of cell proliferation by Smad proteins. J Cell Physiol 2002; 191: 1-16.
10. Yamanaka O, Saika S, Okada Y., et al. Effects of interferon-gamma on human subconjunctival fibroblasts in the presence of TGFβ 1: Reversal of TGFβ -stimulated collagen production. Graefes Arch Clin Exp Ophthalmol 2003; 241: 116-124.
11. Weng H, Mertens PR, Gressner A.M., et al. IFN-γ abrogates profibrogenic TGF-β signaling in liver by targeting expression of inhibitory and receptor Smads. J Hepatol 2007; 46: 295-303.
12. Saika S. TGFβ signal transduction in corneal wound healing as a therapeutic target. Cornea 2004; 23: 25-30.
13. Sakamoto T, Ueno H, Sonoda K., et al. Blockade of TGF-β by in vivo gene transfer of a soluble TGF-β type II receptor in the muscle inhibits corneal opacification, edema and angiogenesis. Gene Ther 2000; 7: 1915-1924.
14. Saika S, Ikeda K, Yamanaka O., et al. Expression of Smad7 in mouse eyes accelerates healing of corneal tissue following exposure to alkali. Am J Pathol 2005; 166: 1405-1418.
15. Saika S, Miyamoto T, Yamanaka O., et al. Therapeutic effect of topical administration of SN50, an inhibitor of NF-κ B, in treatment of corneal alkali burns in mice. Am J Pathol 2005; 166: 1393-1403.
16. Saika S, Ikeda K, Yamanaka O., et al. Therapeutic effects of adenoviral gene transfer of bone morphogenic protein-7 on a corneal alkali injury model in mice. Lab Invest 2005; 85: 474-486.
17. Kawaguchi R, Saika S, Wakayama M., et al. Extracellular matrix components in a case of retrocorneal membrane associated with syphilitic interstitial keratitis. Cornea 2001; 20: 100-103.
18. Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 2002; 3: 155-166.
19. Kalluri R, Neilson EG Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003; 112: 1776-1784.
20. Huber MA, Azoitei N, Baumann B., et al. NF-κ B is essential for epithelialmesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest 2004; 114: 569-581.
21. Lee JM, Dedhar S, Kalluri R., et al. The epithelial-mesenchymal transition: New insights in signaling, development, and disease. J Cell Biol 2006; 172: 973-981.
22. Sumioka T, Ikeda K, Okada Y., et al. Inhibitory effect of blocking TGF-β/Smad signal on injury-induced fibrosis of corneal endothelium. Mol Vis 2008; 14: 2272-2281.
23. Yoon PS, Singh K. Update on antifibrotic use in glaucoma surgery, including use in trabeculectomy and glaucoma drainage implants and combined cataract and glaucoma surgery. Curr Opin Ophthalmol 2004; 15: 141-146.
24. Li J, Campanale NV, Liang R.J., et al. Inhibition of p38 mitogen-activated protein kinase and transforming growth factor-b1/Smad signaling pathways modulates the development of fibrosis in adriamycin-induced nephropathy. Am J Pathol 2006; 169: 1527-1540.
25. Pannu J, Nakerakanti S, Smith E., et al. Transforming growth factor-b receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways. J Biol Chem 2007; 282: 10405-10413.
26. Xavier S, Piek E, Fujii M. Amelioration of radiation-induced fibrosis: Inhibition of transforming growth factor-beta signaling by halofuginone. J Biol Chem 2004; 279: 15167-15176.
27. Kitano A, Saika S, Yamanaka O., et al. Effects of genipin on the behaviors of human subconjunctival fibroblasts in vitro. Ophthalmic Res 2006; 38: 355-360.
28. Kitano A, Saika S, Yamanaka O., et al. Genipin suppression of fibrogenic behaviors of the a-TN4 lens epithelial cell line. J Cataract Refract Surg 2006; 32: 1727-1735.
29. Kitano A, Saika S, Yamanaka O., et al. Emodin suppression of ocular surface inflammatory reaction. Invest Ophthalmol Vis Sci 2007; 48: 5013-5022.
30. Kitano A, Yamanaka O, Ikeda K., et al. Tetrandrine suppresses activation of human subconjunctival fibroblasts in vitro. Curr Eye Res 2008; 33: 559-565.
31. Allocca M, Tessitore A, Cotugno G., et al. AAV-mediated gene transfer for retinal diseases. Expert Opin Biol Ther 2006; 6: 1279-1294.
32. Andrieu-Soler C., Bejjani RA, de Bizemont T, et al. Ocular gene therapy: A review of nonviral strategies. Mol Vis 2006; 12: 1334-1347.
33. Peeters L, Sanders NN, Demeester J, et al. Challenges in non-viral ocular gene transfer. Biochem Soc Trans 2007; 35: 47-49.
34. Mohan RR, Sharma A, Netto M.V., et al. Gene therapy in the cornea. Prog Retin Eye Res 2005; 24: 537-559.